Morningstar Investor users sign in here.

Company Profile

  • Business description

    Plus Therapeutics Inc is a clinical-stage pharmaceutical company. The company focuses on the discovery, development, and delivery of complex treatments for patients battling cancer and rare diseases. Its product pipeline includes Patented RNL and Patented DocePLUS.

  • Contact

    4200 Marathon Boulevard
    Suite 200
    Austin TX 78756
    USA

    T: +1 737 255-7194

    E: ir@plustherapeutics.com

    https://www.plustherapeutics.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    20

Stocks News & Analysis

stocks

Top ASX banking opportunities

Bank shares rally as bad debt concerns ease but look overvalued.
video

The impact on investors from Facebook's about face on news

Morningstar's Director of Equity Research Brian Han talks about why Facebook decided not to renew media deals and the impact for the companies and investors.
stocks

Disappointing offer for undervalued ASX share

Bid from top shareholder 30% less than Morningstar Fair Value Estimate

Markets

Index
Last price
Change
% Change
All Ordinaries 8,050.20 23.90 -0.30%
CAC 40 8,010.83 12.91 -0.16%
DAX 40 17,930.32 24.16 -0.13%
Dow JONES (US) 37,983.24 475.84 -1.24%
FTSE 100 7,995.58 71.78 0.91%
HKSE 16,721.69 373.34 -2.18%
NASDAQ 16,175.09 267.10 -1.62%
Nikkei 225 39,523.55 80.92 0.21%
NZX 50 Index 11,931.32 2.99 -0.03%
S&P 500 5,123.41 75.65 -1.46%
S&P/ASX 200 7,788.10 25.50 -0.33%
SSE Composite Index 3,019.47 14.77 -0.49%

Market Movers

We’re currently having some problems with our data feed. We apologise for any inconvenience.